Author/Editor     Pfeifer, Marija
Title     Morbidna debelost
Translated title     Morbid obesity
Type     članek
Source     In: Omejc M, Repše S, editors. Zbornik simpozija Kirurgija želodca - standardi in novosti; 2005 okt 13-15; Ljubljana. Ljubljana: Klinični oddelek za abdominalno kirurgijo, Klinični center,
Publication year     2005
Volume     str. 11-21
Language     slo
Abstract     Morbidly obese subjects have body mass index (BMI) of 40 to 50, extremely obese of 50 kg/m" or more. Morbid obesity reduces cardiorespiratory fitness and causes comorbidities like type 2 diabetes, hypertension, atherogenic dyslipidaemia, cardiovascular disease, sleep-apnea, nonalcocholic steatohepatitis and cancer. Etiology of morbid obesity is in most cases polygenic although rare monogenic forms are more prevalent among morbidly obese. The "obesogenic" environment enables the manifestation of obesity and is to be blamed for the pandemics of obesity. Nonsurgical treatments of morbidly obese have relaps rates of more than 90 %. Therefore bariatric surgery is the treatment of choice for morbid obesity. An interdisciplinary approach is indicated including general practitioner, physician, bariatric surgeon, psychologist, and dietitian. Fully informed and highly motivated patient is a prerequisite. Before surgery patients should have complete evaluation of obesity parameters and comorbidities, psychological and dietary counseling. After the bariatric procedure patients should be regularly followed by the surgeon, psychologist and dietitian for at least one year. Thereafter once a year follow-up visits are indicated to detect late complications of rapid weight loss and malabsorbtion of nutrients, vitamins and minerals. Bariatric surgery provides reliable and successful treatment option for morbidly obese with sustained weight reduction, improvement or disappearance of comorbidities, especially type 2 diabetes, improvement of quality of life and life expectancy.
Descriptors     OBESITY, MORBID
BODY MASS INDEX
HYPERTENSION
DIABETES MELLITUS, NON-INSULIN-DEPENDENT
HYPERLIPIDEMIA
GASTRIC BYPASS